Literature DB >> 7380833

Kinetics of factor IX activation via the extrinsic pathway. Dependence of Km on tissue factor.

M Zur, Y Nemerson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380833

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  25 in total

1.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Antigen-induced monocyte procoagulant activity. Requirement for antigen presentation and histocompatibility leukocyte antigen-DR molecules.

Authors:  B S Schwartz
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

3.  Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins.

Authors:  S G Spitzer; B J Warn-Cramer; C K Kasper; S P Bajaj
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

4.  Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.

Authors:  G J Broze; J P Miletich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  A sequential mechanism for exosite-mediated factor IX activation by factor XIa.

Authors:  Yipeng Geng; Ingrid M Verhamme; Amanda Messer; Mao-fu Sun; Stephen B Smith; S Paul Bajaj; David Gailani
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

6.  Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation.

Authors:  L V Rao; S I Rapaport
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

7.  Intrinsic versus extrinsic coagulation. Kinetic considerations.

Authors:  B J Warn-Cramer; S P Bajaj
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

Review 8.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.

Authors:  K M Braunstein; C M Noyes; M J Griffith; R L Lundblad; H R Roberts
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

10.  Acquired antibody to factor XI in a patient with congenital factor XI deficiency.

Authors:  D M Stern; H L Nossel; J Owen
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.